DK249287A - Stof eller farmaceutisk praeparat eller kosmetisk praeparat, der haemmer eller oedelaegger mindst et encellet, levende vaesen og/eller mindst et virus, laegemiddel eller produkt indeh. et saadant stof, fremgangsmaade til fremstilling af et saadant stof, kemiskforbindelse indeh. et saadant stof og fremgangsmaadetil inhibering eller oedelaeggelse af mindst et encellet, levende vaesen og/eller mindst et virus - Google Patents

Stof eller farmaceutisk praeparat eller kosmetisk praeparat, der haemmer eller oedelaegger mindst et encellet, levende vaesen og/eller mindst et virus, laegemiddel eller produkt indeh. et saadant stof, fremgangsmaade til fremstilling af et saadant stof, kemiskforbindelse indeh. et saadant stof og fremgangsmaadetil inhibering eller oedelaeggelse af mindst et encellet, levende vaesen og/eller mindst et virus

Info

Publication number
DK249287A
DK249287A DK249287A DK249287A DK249287A DK 249287 A DK249287 A DK 249287A DK 249287 A DK249287 A DK 249287A DK 249287 A DK249287 A DK 249287A DK 249287 A DK249287 A DK 249287A
Authority
DK
Denmark
Prior art keywords
substance
virus
procedure
cell
destroying
Prior art date
Application number
DK249287A
Other languages
English (en)
Other versions
DK173716B1 (da
DK249287D0 (da
Inventor
Pierre Bourbon
Pierre Langny
Pierre Billot
Original Assignee
Atlantic Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8607310A external-priority patent/FR2598916B1/fr
Application filed by Atlantic Pharma Prod filed Critical Atlantic Pharma Prod
Publication of DK249287D0 publication Critical patent/DK249287D0/da
Publication of DK249287A publication Critical patent/DK249287A/da
Application granted granted Critical
Publication of DK173716B1 publication Critical patent/DK173716B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/10—Fluorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Oncology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
DK198702492A 1986-05-22 1987-05-14 Ikke-farmaceutisk komposition som indeholder en overfladeaktiv forbindelse og en fluorforbindelse DK173716B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR8607310 1986-05-22
FR8607310A FR2598916B1 (fr) 1986-05-22 1986-05-22 Compose chimique fluore utilise dans une methode de contraception locale et composition contraceptive locale fluoree, notamment spermicide
EP86402716A EP0253037B1 (fr) 1986-05-22 1986-12-08 Composition inhibitrice d'au moins un être vivant unicellulaire et/ou virus, procédé de fabrication et applications de cette composition
EP86402716 1986-12-08

Publications (3)

Publication Number Publication Date
DK249287D0 DK249287D0 (da) 1987-05-14
DK249287A true DK249287A (da) 1987-11-23
DK173716B1 DK173716B1 (da) 2001-07-23

Family

ID=26106166

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198702492A DK173716B1 (da) 1986-05-22 1987-05-14 Ikke-farmaceutisk komposition som indeholder en overfladeaktiv forbindelse og en fluorforbindelse

Country Status (14)

Country Link
JP (1) JP2559735B2 (da)
CN (1) CN87103752A (da)
AT (1) ATE64854T1 (da)
AU (1) AU7331287A (da)
BR (1) BR8702645A (da)
CA (1) CA1326446C (da)
DK (1) DK173716B1 (da)
FI (1) FI89675C (da)
HU (1) HUT43793A (da)
IE (1) IE60364B1 (da)
IL (1) IL82523A (da)
NO (1) NO872142L (da)
OA (1) OA08799A (da)
WO (1) WO1987007143A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620620B1 (fr) * 1987-09-22 1991-04-05 Atlantic Pharma Prod Substance inhibitrice ou destructrice d'au moins un etre vivant unicellulaire renfermant du fluor f- et du lithium li+
ATE78396T1 (de) * 1987-09-23 1992-08-15 Atlantic Pharma Prod Zusammensetzung zur hemmung oder vernichtung mindestens eines einzelligen lebewesens, enthaltend ein quaternaeres ammoniumfluorid, und verfahren zur herstellung dieses salzes.
GB8809177D0 (en) * 1988-04-19 1988-05-25 Merrell Doe Pharmaceuticals In Method of preventing aids transmission-resulting from blood transfusions
DE4236090C1 (de) * 1992-10-26 1994-01-05 Asta Medica Arzneimittel Pharmazeutische Zubereitung für die Fluoridionen-Versorgung
US5658946A (en) * 1996-05-29 1997-08-19 The Procter & Gamble Company Methods for the treatment of herpes virus infections
RU2259825C9 (ru) 2001-06-18 2006-04-10 БиоДием Лимитед Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности
JP4759104B2 (ja) * 2005-08-26 2011-08-31 株式会社ユネクス センサ保持装置
JP6204729B2 (ja) * 2013-07-10 2017-09-27 花王株式会社 水溶性ポリマー組成物
WO2015161860A1 (en) * 2014-04-25 2015-10-29 Frank Flechsig Improved biocide compositions based on calcium fluoride as well as uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH448388A (de) * 1963-12-30 1967-12-15 Ciba Geigy Neues Zahnpflegemittel
US3647700A (en) * 1967-08-14 1972-03-07 Commodity Improvements Inc K2zrf6
US3995029A (en) * 1975-01-02 1976-11-30 Geraldine Fay Weisz Methods for the treatment of acne
US3996350A (en) * 1975-01-02 1976-12-07 Geraldine Fay Weisz Methods and compositions for alleviating fungus infections of the skin
US4097590A (en) * 1975-07-24 1978-06-27 Geraldine Fay Weisz Methods and compositions for treatment of bacterial and fungus infections of the skin
SE444112B (sv) * 1978-06-15 1986-03-24 Dental Therapeutics Ab Rengoringsmedel for dentinytor
US4368186A (en) * 1981-05-07 1983-01-11 Syntex (U.S.A.) Inc. Methods and compositions for intravaginal contraception
US4359475A (en) * 1981-12-21 1982-11-16 Syntex (U.S.A.) Inc. Thioketal substituted N-alkyl imidazoles
US4473547A (en) * 1982-11-18 1984-09-25 Johnson & Johnson Products Inc. Anticaries compositions

Also Published As

Publication number Publication date
AU7331287A (en) 1987-11-26
NO872142L (no) 1987-11-23
FI872253A (fi) 1987-11-23
IE871338L (en) 1987-11-22
JP2559735B2 (ja) 1996-12-04
ATE64854T1 (de) 1991-07-15
IL82523A (en) 1992-05-25
DK173716B1 (da) 2001-07-23
WO1987007143A1 (fr) 1987-12-03
BR8702645A (pt) 1988-02-23
JPS6322023A (ja) 1988-01-29
CA1326446C (en) 1994-01-25
FI89675B (fi) 1993-07-30
IL82523A0 (en) 1987-11-30
OA08799A (fr) 1989-03-31
FI872253A0 (fi) 1987-05-21
HUT43793A (en) 1987-12-28
IE60364B1 (en) 1994-07-13
CN87103752A (zh) 1988-09-21
DK249287D0 (da) 1987-05-14
NO872142D0 (no) 1987-05-21
FI89675C (fi) 1993-11-10

Similar Documents

Publication Publication Date Title
NO885213D0 (no) Stabiliserte legemidler, fremgangsmŸte til deres fremstilling samt stabile legemiddeltilberedninger.
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
GT199900069A (es) Preparaciones farmaceuticas estabilizadas de gabapentina y proceso para prepararla.
FI973419A0 (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
DK471085D0 (da) Farmaceutiske sammensaetninger indeholdende syntetiske phospholipiderog et farmaceutisk aktivt stof samt deres fremstilling og anvendelse
DE3580140D1 (de) Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel.
DK249287A (da) Stof eller farmaceutisk praeparat eller kosmetisk praeparat, der haemmer eller oedelaegger mindst et encellet, levende vaesen og/eller mindst et virus, laegemiddel eller produkt indeh. et saadant stof, fremgangsmaade til fremstilling af et saadant stof, kemiskforbindelse indeh. et saadant stof og fremgangsmaadetil inhibering eller oedelaeggelse af mindst et encellet, levende vaesen og/eller mindst et virus
ATE33556T1 (de) Adenosinderivate enthaltende pharmazeutische zusammensetzung fuer behandlung von tumoren.
BR9913782A (pt) Processo de preparação de uma formualação galênica que compreende fenofibrato como princìpio ativo, formulação galênica, medicamento e utilizações de um meio lìquido e de partìculas de fenofibrato
ES2033021T3 (es) Agente con efecto destructivo a tumores malignos, procedimiento para su obtencion y preparacion para la aplicacion en la terapia de enfermos de cancer.
ATE110529T1 (de) Arzneimittelzubereitung zur systemischen behandlung von zier- und nutzfischen.
ES2041243T3 (es) Aplicacion de por lo menos un principio activo inhibidor o destructor de por lo menos un ser vivo unicelular o virus.
DE69230491D1 (de) Transformierte zellen zur verhütung oder zur behandlung von virus-induzierten erkrankungen,besonders pathogenen retroviren
FI951961A (fi) Tilidiinidivetyortofosfatti, menetelmä sen valmistamiseksi ja sitä sisältäviä farmaseuttisia valmisteita
FI65616B (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara 1-oxadiazolylfenoxi-3-(4-fenylpiperazinyl)-propanol-2-derivat
ATE8880T1 (de) Neue carbamate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DK116689D0 (da) Pyrroloquinolin- og pyrrolophenothiazin-carboxamider og beslaegtede forbindelser samt farmaceutiske praeparater indeholdende disse og deres anvendelse til fremstilling af laegemidler til behandling af inflammation eller andre prostaglandin- eller leukotrin-formidlede sygdomme
IT7924769A0 (it) Derivati di acidi aziridin-2-carbossilici n-sostituiti con attivita'immunostimolante, processi per laloro preparazione e farmaci contenenti tali sostanze.
PT85454A (de) Verwendung von 15-deoxyspergualin als arzneimittel
ES407144A1 (es) Procedimiento para la fotoestabilizacion de hormonas de la metamorfosis de los insectos.
SE8202962L (sv) 2-metoxifenylestrar av n-substiterade aminosyror, forfarande for deras framstellning och farmaceutiska beredningar innehallande desamma
NL177404C (nl) 4-aryl-5-aminoalkyl-1,3-dioxolonen, hun farmaceutisch geschikte zouten, werkwijze voor hun bereiding, alsmede geneesmiddelen met deze dioxolonen of hun zouten als aktieve stoffen daarin.
DK412288A (da) Leukotrienantagonister, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
ATE88342T1 (de) Pharmazeutische zubereitungen zur behandlung der psoriasis, psoriatischen arthritis, neurodermitis und enteritis regionalis crohn.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK